Sustained Functional Improvement by Hepatocyte Growth Factor-Like Small Molecule BB3 after Focal Cerebral Ischemia in Rats and Mice
Authors:
Open Access
- 25 February 2015
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 35 (6) , 1044-1053
Abstract
Hepatocyte growth factor (HGF), efficacious in preclinical models of acute central nervous system injury, is burdened by administration of full-length proteins. A multiinstitutional consortium investigated the efficacy of BB3, a small molecule with HGF-like activity that crosses the blood-brain barrier in rodent focal ischemic stroke using Stroke Therapy Academic Industry Roundtable (STAIR) and Good Laboratory Practice guidelines. In rats, BB3, begun 6 hours after temporary middle cerebral artery occlusion (tMCAO) reperfusion, or permanent middle cerebral artery occlusion (pMCAO) onset, and continued for 14 days consistently improved long-term neurologic function independent of sex, age, or laboratory. BB3 had little effect on cerebral infarct size and no effect on blood pressure. BB3 increased HGF receptor c-Met phosphorylation and synaptophysin expression in penumbral tissue consistent with a neurorestorative mechanism from HGF-like activity. In mouse tMCAO, BB3 starting 10 minutes after reperfusion and continued for 14 days improved neurologic function that persisted for 8 weeks in some, but not all measures. Study in animals with comorbidities and those exposed to common stroke drugs are the next steps to complete preclinical assessment. These data, generated in independent, masked, and rigorously controlled settings, are the first to suggest that the HGF pathway can potentially be harnessed by BB3 for neurologic benefit after ischemic stroke.Keywords
This publication has 41 references indexed in Scilit:
- RIGOR Guidelines: Escalating STAIR and STEPS for Effective Translational ResearchTranslational Stroke Research, 2012
- Neuroprotective Efficacy from a Lipophilic Redox-Modulating Mn(III) N-Hexylpyridylporphyrin, MnTnHex-2-PyP: Rodent Models of Ischemic Stroke and Subarachnoid HemorrhageThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Pharmacologically Augmented S -Nitrosylated Hemoglobin Improves Recovery From Murine Subarachnoid HemorrhageStroke, 2011
- HGF/c-Met pathway has a prominent role in mediating antiapoptotic signals through AKT in epithelial ovarian carcinomaLaboratory Investigation, 2011
- Acute Hepatocyte Growth Factor Treatment Induces Long-Term Neuroprotection and Stroke Recovery via Mechanisms Involving Neural Precursor Cell Proliferation and DifferentiationJournal of Cerebral Blood Flow & Metabolism, 2010
- Long-term neuroprotection from a potent redox-modulating metalloporphyrin in the ratFree Radical Biology and Medicine, 2009
- Assessing Reproductive Status/Stages in MiceCurrent Protocols in Neuroscience, 2009
- Update of the Stroke Therapy Academic Industry Roundtable Preclinical RecommendationsStroke, 2009
- Reprint: Good Laboratory Practice: Preventing Introduction of Bias at the BenchJournal of Cerebral Blood Flow & Metabolism, 2008
- Neurological Deficit and Extent of Neuronal Necrosis Attributable to Middle Cerebral Artery Occlusion in RatsStroke, 1995